Insufficient scRNA-seq data for expression of PRKAG3 at single-cell level.
Insufficient scRNA-seq data for expression of PRKAG3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 3148.00 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 80% | 24.24 | 692 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 78% | 28.96 | 1041 / 1335 | 0% | 0 | 0 / 0 |
prostate | 69% | 40.10 | 168 / 245 | 4% | 0.15 | 20 / 502 |
skin | 68% | 16.00 | 1223 / 1809 | 2% | 0.04 | 11 / 472 |
bladder | 62% | 7.00 | 13 / 21 | 1% | 0.01 | 3 / 504 |
lung | 44% | 5.27 | 252 / 578 | 3% | 0.14 | 35 / 1155 |
liver | 40% | 4.48 | 91 / 226 | 0% | 0 | 0 / 406 |
breast | 32% | 5.49 | 145 / 459 | 5% | 0.17 | 58 / 1118 |
esophagus | 31% | 4.91 | 455 / 1445 | 2% | 0.05 | 4 / 183 |
brain | 33% | 13.15 | 865 / 2642 | 0% | 0.01 | 1 / 705 |
adipose | 32% | 4.71 | 383 / 1204 | 0% | 0 | 0 / 0 |
intestine | 27% | 2.47 | 262 / 966 | 0% | 0.01 | 2 / 527 |
ovary | 14% | 1.28 | 26 / 180 | 3% | 0.08 | 12 / 430 |
uterus | 14% | 1.21 | 23 / 170 | 3% | 0.32 | 16 / 459 |
peripheral blood | 17% | 4.59 | 154 / 929 | 0% | 0 | 0 / 0 |
thymus | 16% | 3.05 | 106 / 653 | 0% | 0.01 | 2 / 605 |
kidney | 13% | 0.94 | 12 / 89 | 0% | 0.01 | 3 / 901 |
stomach | 10% | 0.82 | 35 / 359 | 1% | 0.01 | 2 / 286 |
spleen | 8% | 0.85 | 20 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 0.55 | 19 / 258 | 0% | 0.00 | 1 / 230 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.21 | 2 / 45 |
pancreas | 2% | 0.26 | 8 / 328 | 0% | 0 | 0 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0006096 | Biological process | glycolytic process |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0050790 | Biological process | regulation of catalytic activity |
GO_0006468 | Biological process | protein phosphorylation |
GO_0014873 | Biological process | response to muscle activity involved in regulation of muscle adaptation |
GO_0005615 | Cellular component | extracellular space |
GO_0031588 | Cellular component | nucleotide-activated protein kinase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019887 | Molecular function | protein kinase regulator activity |
GO_0016208 | Molecular function | AMP binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004679 | Molecular function | AMP-activated protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKAG3 |
Protein name | Protein kinase AMP-activated non-catalytic subunit gamma 3 Protein kinase AMP-activated non-catalytic subunit gamma 3 (cDNA FLJ60036, highly similar to 5'-AMP-activated protein kinase subunit gamma-3) 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) Alternative protein PRKAG3 |
Synonyms | AMPKG3 |
Description | FUNCTION: AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism . In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. AMPK also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. The AMPK gamma3 subunit is a non-catalytic subunit with a regulatory role in muscle energy metabolism . It mediates binding to AMP, ADP and ATP, leading to AMPK activation or inhibition: AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits. ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit. ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive. . |
Accessions | C9JIC7 B4DUK8 Q9UGI9 ENST00000430489.1 ENST00000470307.6 ENST00000439262.7 [Q9UGI9-1] L8EAW7 ENST00000529249.5 [Q9UGI9-1] |